Vishal Kapadia
@kapadianeo.bsky.social
Neonatologist. Researcher. Passionate about neonatal resuscitation, optimization of oxygen use, evidence based medicine, quality improvement and innovation. Opinions are my own.
Reposted by Vishal Kapadia
If you haven’t caught up on the PLUSS trial results yet, published a few days ago in JAMA #neosky #nicusky
Link to paper: jamanetwork.com/journals/jam...
Link to editorial: jamanetwork.com/journals/jam...
Link to audio podcast: edhub.ama-assn.org/jn-learning/...
Link to paper: jamanetwork.com/journals/jam...
Link to editorial: jamanetwork.com/journals/jam...
Link to audio podcast: edhub.ama-assn.org/jn-learning/...
Intratracheal Budesonide Mixed With Surfactant for Extremely Preterm Infants
This randomized trial assesses the effect of intratracheal budesonide mixed with surfactant on survival free of bronchopulmonary dysplasia in extremely preterm infants.
jamanetwork.com
November 15, 2024 at 8:48 PM
If you haven’t caught up on the PLUSS trial results yet, published a few days ago in JAMA #neosky #nicusky
Link to paper: jamanetwork.com/journals/jam...
Link to editorial: jamanetwork.com/journals/jam...
Link to audio podcast: edhub.ama-assn.org/jn-learning/...
Link to paper: jamanetwork.com/journals/jam...
Link to editorial: jamanetwork.com/journals/jam...
Link to audio podcast: edhub.ama-assn.org/jn-learning/...
Reposted by Vishal Kapadia
Hi 👋— We are excited to see what happens over here and connect with our favorite #Neonatology and #ChildNeurology friends as well as #HIE families!
Hope for HIE is the premiere global patient advocacy and support org for neonatal and pediatric-acquired HIE.
🧠☀️🩵🎉
Hope for HIE is the premiere global patient advocacy and support org for neonatal and pediatric-acquired HIE.
🧠☀️🩵🎉
November 14, 2024 at 10:52 PM
Hi 👋— We are excited to see what happens over here and connect with our favorite #Neonatology and #ChildNeurology friends as well as #HIE families!
Hope for HIE is the premiere global patient advocacy and support org for neonatal and pediatric-acquired HIE.
🧠☀️🩵🎉
Hope for HIE is the premiere global patient advocacy and support org for neonatal and pediatric-acquired HIE.
🧠☀️🩵🎉
Reposted by Vishal Kapadia
As a welcome to our new BlueSky Friends, we just got a 30% discount code for the book below through Oxford University Press. Happy reading!
#NeoSky #NeoEBM
global.oup.com/academic/pro... and enter code AMPROMD9 at checkout
#NeoSky #NeoEBM
global.oup.com/academic/pro... and enter code AMPROMD9 at checkout
November 16, 2024 at 2:23 PM
As a welcome to our new BlueSky Friends, we just got a 30% discount code for the book below through Oxford University Press. Happy reading!
#NeoSky #NeoEBM
global.oup.com/academic/pro... and enter code AMPROMD9 at checkout
#NeoSky #NeoEBM
global.oup.com/academic/pro... and enter code AMPROMD9 at checkout
Reposted by Vishal Kapadia
A reasonably balanced article in the Guardian, about profoundly immature newborns. Interesting how often pain is mentioned as the major downside of active NICU care, vitally important to parents and the public.
#Neosky
www.theguardian.com/society/2024...
#Neosky
www.theguardian.com/society/2024...
‘Look, they’re getting skin!’: are we right to strive to save the world’s tiniest babies?
The long read: Doctors are pushing the limits of science and human biology to save more extremely premature babies than ever before. But when so few survive, are we putting them through needless suffe...
www.theguardian.com
November 19, 2024 at 2:31 PM
A reasonably balanced article in the Guardian, about profoundly immature newborns. Interesting how often pain is mentioned as the major downside of active NICU care, vitally important to parents and the public.
#Neosky
www.theguardian.com/society/2024...
#Neosky
www.theguardian.com/society/2024...
Reposted by Vishal Kapadia
November 15, 2024 at 2:26 AM
Reposted by Vishal Kapadia
Moving #52MoreChallenge (ClassicNeo non-RCTs) to BSky! (& repeating 1st month)
Week 1 - of course - belongs to Dr. Mel Avery:
Avery M, Mead J. Surface properties in relation to atelectasis & HMD. AMA J Dis Children. 1959;97(5,Pt1):517-23
pubmed.ncbi.nlm.nih.gov/13649082/
#neoSky #neoEBM 🧵
Week 1 - of course - belongs to Dr. Mel Avery:
Avery M, Mead J. Surface properties in relation to atelectasis & HMD. AMA J Dis Children. 1959;97(5,Pt1):517-23
pubmed.ncbi.nlm.nih.gov/13649082/
#neoSky #neoEBM 🧵
Surface properties in relation to atelectasis and hyaline membrane disease - PubMed
Surface properties in relation to atelectasis and hyaline membrane disease
pubmed.ncbi.nlm.nih.gov
November 19, 2024 at 1:30 AM
Moving #52MoreChallenge (ClassicNeo non-RCTs) to BSky! (& repeating 1st month)
Week 1 - of course - belongs to Dr. Mel Avery:
Avery M, Mead J. Surface properties in relation to atelectasis & HMD. AMA J Dis Children. 1959;97(5,Pt1):517-23
pubmed.ncbi.nlm.nih.gov/13649082/
#neoSky #neoEBM 🧵
Week 1 - of course - belongs to Dr. Mel Avery:
Avery M, Mead J. Surface properties in relation to atelectasis & HMD. AMA J Dis Children. 1959;97(5,Pt1):517-23
pubmed.ncbi.nlm.nih.gov/13649082/
#neoSky #neoEBM 🧵
Reposted by Vishal Kapadia
Updated meta-regression by Prof Lex Doyle et al. in JAMA Pediatrics examines how potential benefit from Dexamethasone and Hydrocortisone changes with baseline risk of BPD among included trials. #neoEBM #neosky #EBNEOalerts
buff.ly/3CNa6Ae
buff.ly/3CNa6Ae
November 21, 2024 at 1:34 PM
Updated meta-regression by Prof Lex Doyle et al. in JAMA Pediatrics examines how potential benefit from Dexamethasone and Hydrocortisone changes with baseline risk of BPD among included trials. #neoEBM #neosky #EBNEOalerts
buff.ly/3CNa6Ae
buff.ly/3CNa6Ae